Microsoft’s New Diagnostic Results Face a Real-World Test
Sequential diagnosis results highlight the importance of evaluation design, while prospective clinical testing remains ahead.
Share
Healthcare & Life Sciences
62 posts
Coherence’s $45 Million Round Backs Experimental Cancer Neurotechnology
Coherence's new financing supports an experimental path from animal recordings and short human studies toward chronic use, not an already approved cancer therapy.
Share
Nurses Challenge HCA’s AI Scheduling as the Company Defends Human Oversight
Nurses interviewed by WIRED raise concerns about Timpani's schedules and correction process. HCA disputes claims that the system sacrifices care and says nursing leaders retain final authority.
Share
Anthropic’s AI Biology Claim Meets the Lab-Test Question
Claude agents surfaced a Crispr-like genetic pattern, but outside scientists say the system's function and value still require laboratory proof.
Share
AI Biotech’s Biggest Constraint Is Its Data
Investor and scientist Vijay Pande argues that AI can improve drug development and precision medicine, but scarce, siloed biological data limits what models can deliver.
Share
Autonomous Medical AI Challenges the Doctor’s Role
A prominent medical paper predicts AI-only care could outperform doctors and human-AI teams, while clinicians challenge its evidence and implications.
Share
Legato Emerges With $12 Million for AI Hearing Glasses
Legato is placing AI-assisted voice separation inside ordinary-looking glasses, with a launch planned through selected eye-care providers later this year.
Share
Outer Biosciences Trains AI on Living Skin to Find Cosmetic Ingredients
Outer Biosciences says its closed AI and living-tissue feedback loop can accelerate cosmetic ingredient discovery, though commercial validation remains ahead.
Share
Vivodyne Bets Better Human-Tissue Data Can Move AI Drug Discovery Forward
Vivodyne is building robotic laboratories around living human tissue, arguing that AI drug discovery needs causal experimental data rather than more predictions from existing datasets.
Share
Samsung’s Wearable AI Models Aim to Read Health Signals on the Wrist
Samsung has presented two foundation models for wearable biosignals, targeting continuous cardiac and activity analysis while keeping major claims at the research stage.
Share